In vitro binding of hepatitis C virus to CD81-positive and -negative human cell lines

Journal of Gastroenterology and Hepatology (Australia)

Volumn 18, Issue 1, 2003, Pages 74-79

  Sasaki, Mina ^a   Yamauchi, Katsumi ^a   Nakanishi, Toshimi ^a   Kamogawa, Yumiko ^b   Hayashi, Naoaki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

CD81; Chain reaction; Hepatitis C virus; In vitro binding; Reverse transcriptase polymerase; Transfection

Indexed keywords

CD81 ANTIGEN; VIRUS RNA;

ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CELL; MOLECULE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 0037228439     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.2003.02925.x     Document Type: Article

References (25)

1. McOmish F, Yap PL, Dow BCet al. Geographical distribution of hepatitis C virus genotypes in blood donors: An international collaboration survey. J. Clin. Microbiol. 1994; 32: 884-92.
2. Tong MJ, El-Farra NS, Reikes AS, Co RL. Clinical outcomes after transfusion-associated hepatitis C. N. Engl. J. Med. 1996; 332: 1463-6.
3. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26(Suppl.); S62-5.
4. Saito I, Miyamura A, Ohbayashi H et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc. Natl Acad. Sci. USA 1990; 87: 6547-9.
5. Miller RH, Purcell RH. Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus subgroups. Proc. Natl Acad. Sci. USA 1990; 87: 2057-67.
6. Reed KE, Rice CM. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties. Curr. Top. Microbiol. Immunol. 2000; 242: 55-84.
7. Pierli P, Umematsu Y, Campagnoli S et al. Binding of hepatitis C virus to CD81. Science 1998; 282: 938-41.
8. Flint M, Maidens C, Loomis-Price LDet al. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 1999; 73: 6235-44.
9. Flint M, Thomas JM, Maidens CMet al. Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J. Virol. 1999; 73: 6782-90.
10. Flint M, Dubuisson J, Maidens Cet al. Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein. J. Virol. 2000; 74: 702-9.
11. Levy S, Todd SC, Maecker HT. CD81 (TAPA-1): a molecule involved in signal transduction and cell adhesion in the immune system. Ann. Rev. Immunol. 1998; 16: 89-109.
12. Jacquelyn M. Is CD81 the key to hepatitis C virus entry. Hepatology 1999; 29: 990-2.
13. Zibert A, Schreier E, Roggendorf M. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 1995; 208: 653-61.
14. Zhou YH, Shimizu Y, Esumi M. Monoclonal antibodies to hypervariable region 1 of hepatitis C virus capture virus and inhibit virus adsorption to susceptible cells in vitro. Virology 2000; 269: 276-83.
15. Okamoto H, Okada S, Sugiyama Y et al. Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced in the 5′-noncoding region. Japan J. Exp. Med. 1990; 60: 215-22.
16. Kurata H, Lee HJ, O'Garra A, Arai N. Ectopic expression of activated Stat6 induces the expression of Th2-specific cytokines and transcription factors in developing Th1 cells. Immunity 1999; 11: 677-88.
17. Seipp S, Mueller HM, Pfaff E, Stremmel W, Theilmann L, Goeser T. Establishment of persistent hepatitis C virus infection and replicationin vitro. J. Gen. Virol. 1997; 78: 2487-76.
18. Bronowicki JP, Loriot MA, Theiers V, Grignon W, Zignego AL, Brecho C. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. Hepatology 1998; 28: 211-18.
19. Vita SD, De RV, Sansonno Det al. Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: Viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis.Hepatology 2000; 31: 182-9.
20. Petracca R, Falugi F, Galli G et al. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J. Virol. 2000; 74: 4824-30.
21. Agenello V, Elfehal M, Knight GB, Abel G, Zhang QX. CD81 is not a receptor or co-receptor for cell entry of HCV. Antiviral Therapy 2000; 4: c129 (Abstract).
22. Kimberland M, Erickson-Viitanen S, Pasquinelli C. CD81 over-expression does not facilitate HCV replication in a human hepatocyte cell line. Antiviral Therapy 2000; 5: c139 (Abstract).
23. Meola A, Sbardellati A, Ercole BB et al. Binding of hepatitis virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection. J. Virol. 2000; 74: 5933-8.
24. Monazahian M, Bohme I, Bonk Set al. Low density lipo-protein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 1999; 57: 223-9.
25. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.Proc. Natl Acad. Sci. USA 1999; 96: 12 766-71.